Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 5/20 | 0.53 |
| ▸ | ACHE | P22303 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | CACNB4 | O00305 | 1/20 | 0.53 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.53 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.53 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.53 |
| ▸ | CACNG3 | O60359 | 1/20 | 0.53 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.53 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.53 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | FABP1 | P07148 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14572403 | 0.94 | BCHE (0.53) | KMT2ABCHEACHEALDH1A1TSHR | |
| SCHEMBL7695584 | 0.82 | NPC1 (0.58) | KMT2ABCHEACHEALDH1A1TSHR | |
| SCHEMBL25409087 | 0.79 | MAPT (0.48) | KMT2ABCHEACHEALDH1A1TSHR | |
| SCHEMBL26363970 | 0.79 | MAPT (0.48) | KMT2ABCHEACHEALDH1A1TSHR | |
| SCHEMBL25409084 | 0.79 | MAPT (0.48) | KMT2ABCHEACHEALDH1A1TSHR | |
| SCHEMBL6313436 | 0.77 | HTR2C (0.48) | ALDH1A1HSD17B10CYP1A2KDM4ECYP3A4 | |
| SCHEMBL452908 | 0.75 | NPC1 (0.49) | KMT2ABCHEACHEALDH1A1TSHR | |
| SCHEMBL9823209 | 0.74 | HTT (0.47) | KMT2ABCHEACHEALDH1A1TSHR | |
| SCHEMBL8326392 | 0.74 | ACHE (0.54) | BCHEACHEALDH1A1TSHRHSD17B10 | |
| SCHEMBL9347454 | 0.74 | KMT2A (0.48) | KMT2ABCHEACHEALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110776472-B | Preparation method of tetrahydrophenazine derivative | 五邑大学 | 2022-04-22 | — | — | CN | claimed |
| CN-110776472-A | Preparation method of tetrahydrophenazine derivative | 五邑大学 | 2020-02-11 | — | — | CN | claimed |
| WO-2013005170-A2 | INHIBITORS OF AQUAGLYCEROPORINS, METHODS AND USES THEREOF | UNIVERSIDADE DE LISBOA (PT) | 2013-01-10 | — | — | WO | claimed |
| US-20260146047-A1 | MACROCYCLIC HETEROCYCLE COMPOUNDS AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-05-28 | — | — | US | disclosed |
| US-12637418-B2 | Heterocyclic compounds as antagonist of NMDA | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-05-26 | — | — | US | disclosed |
| CN-122071471-A | Heterocyclic compounds | 武田药品工业株式会社 | 2026-05-22 | — | — | CN | disclosed |
| EP-3617208-B1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2026-05-13 | — | — | EP | disclosed |
| CN-122010945-A | Heterocyclic compounds | 武田药品工业株式会社 | 2026-05-12 | — | — | CN | disclosed |
| CN-122010946-A | Heterocyclic compounds | 武田药品工业株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-20260092033-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2026-04-02 | — | — | US | disclosed |
| US-12534471-B2 | Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-01-27 | — | — | US | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0237915-A2 | Chromogenic phthalides, their preparation and use | BAYER AG (DE) | 1987-09-23 | — | — | EP | disclosed |
| EP-0092862-B1 | PROCESS FOR THE OXIDATION OF TERTIARY AMINES TO AMINE OXIDES | THE PROCTER & GAMBLE COMPANY (US) | 1986-03-12 | — | — | EP | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4565891-A | Oxidation of tertiary amines using octacyanomolybdate or iron (III) salts as catalysts | THE PROCTER & GAMBLE COMPANY (US) | 1986-01-21 | — | — | US | disclosed |
| EP-0092862-A1 | Process for the oxidation of tertiary amines to amine oxides | THE PROCTER & GAMBLE COMPANY (US) | 1983-11-02 | — | — | EP | disclosed |
| US-4140686-A | BY RECRYSTALLIZATION FROM AN ALKYL ESTER OF AN ALIPHATIC CARBOXYLIC ACID | TORAY INDUSTRIES, INC. (JP) | 1979-02-20 | — | — | US | disclosed |
| US-4140686-A | BY RECRYSTALLIZATION FROM AN ALKYL ESTER OF AN ALIPHATIC CARBOXYLIC ACID | TORAY INDUSTRIES, INC. (JP) | 1979-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092033-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | HCRTR2, HCRTR1, MTNR1B | KMT2A 186/4885BCHE 745/4885ACHE 2739/4885 |
| US-12637418-B2 | Heterocyclic compounds as antagonist of NMDA | GRIN1, GRIN3A, GRIN2A | KMT2A 625/4885BCHE 837/4885ACHE 690/4885 |
| US-20260146047-A1 | MACROCYCLIC HETEROCYCLE COMPOUNDS AND USE THEREOF | HCRTR2, HCRTR1, NPY1R | KMT2A 507/4885BCHE 1795/4885ACHE 3754/4885 |
| US-12534471-B2 | Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof | HCRTR2, HCRTR1, NPY1R | KMT2A 1264/4885BCHE 719/4885ACHE 1248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.